Stay updated on VAX-24 Safety and Immunogenicity in Adults Clinical Trial

Sign up to get notified when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The page footer was updated from **Revision v3.5.2** to **Revision v3.5.3**, reflecting a site/version release.
    Difference
    0.0%
    Check dated 2026-04-26T15:16:54.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-19T12:52:07.000Z thumbnail image
  4. Check
    26 days ago
    No Change Detected
  5. Check
    47 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-21T09:13:22.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.2 to v3.4.3 on the page.
    Difference
    0.0%
    Check dated 2026-03-06T19:16:25.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Revision indicator updated from v3.4.1 to v3.4.2 appears in the page footer. No study data, sections, or functionality were modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-13T12:51:49.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T21:48:17.000Z thumbnail image

Stay in the know with updates to VAX-24 Safety and Immunogenicity in Adults Clinical Trial

Enter your email address, and we'll notify you when there's something new on the VAX-24 Safety and Immunogenicity in Adults Clinical Trial page.